EV Biologics, Inc. (YECO)

EV Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2017	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2017	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014
Cash & Equivalents	8.39	1.81	2.73	16.47	19.73
Short-Term Investments	4.02	-	-	-	-
Cash & Short-Term Investments	12.4	1.81	2.73	16.47	19.73
Cash Growth	583.85%	-33.67%	-83.40%	-16.53%	240.65%
Accounts Receivable	1.03	4.97	5.73	9.33	5.18
Other Receivables	-	0.02	0.02	-	-
Receivables	1.03	4.98	5.74	9.33	6.11
Inventory	0.13	0.21	0.36	0.36	0.42
Prepaid Expenses	0.11	0.08	0.11	0.37	0.07
Restricted Cash	-	0.5	0.5	-	-
Other Current Assets	38.38	1.33	1.21	0.3	0.41
Total Current Assets	52.05	8.91	10.66	26.84	26.75
Property, Plant & Equipment	5.16	6.66	7.43	41.27	34.38
Other Intangible Assets	1.75	2.07	2.16	4.91	2.83
Long-Term Deferred Tax Assets	-	0.16	0.39	0.52	0.19
Other Long-Term Assets	-	15.49	15.8	4.06	5.4
Total Assets	58.95	33.28	36.44	77.6	69.56

Liabilities

Fiscal Year	FY 2017	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2017	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014
Accounts Payable	1.66	2.3	1.71	1.73	1.82
Accrued Expenses	0.08	0.42	0.44	0.29	0.22
Short-Term Debt	6.47	7.04	7.64	10.56	7.93
Current Portion of Leases	-	4.8	4.06	4.62	1.61
Current Income Taxes Payable	-	0.98	1.13	0.98	0.95
Current Unearned Revenue	-	4.45	2.57	-	0.4
Other Current Liabilities	8.51	9.57	7.6	12.63	0.68
Total Current Liabilities	16.72	29.56	25.15	30.81	13.62
Long-Term Debt	-	-	-	-	9.8
Long-Term Leases	-	-	0.03	0.14	0.07
Other Long-Term Liabilities	-	-	-	-	8.42
Total Liabilities	16.72	29.56	25.18	30.95	31.91

Shareholders' Equity

Fiscal Year	FY 2017	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2017	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014
Common Stock	8.68	0	0	0.01	0.01
Additional Paid-In Capital	15.27	40.71	40.51	19.01	19.01
Retained Earnings	18.28	-35.49	-28.06	25.13	16.45
Comprehensive Income & Other	-	-1.51	-1.19	2.5	2.17
Shareholders' Equity	42.23	3.72	11.26	46.65	37.65
Total Liabilities & Equity	58.95	33.28	36.44	77.6	69.56

Additional Metrics

Fiscal Year	FY 2017	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2017	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014
Total Debt	6.47	11.85	11.73	15.31	19.41
Net Cash (Debt)	5.94	-10.03	-9	1.16	0.32
Net Cash Growth	-	-	-	262.99%	-
Net Cash Per Share	2.46	-4.16	-3.77	0.72	0.20
Filing Date Shares Outstanding	27.41	2.41	2.4	1.6	1.6
Total Common Shares Outstanding	2.41	2.41	2.4	1.6	1.6
Working Capital	35.33	-20.65	-14.49	-3.97	13.14
Book Value Per Share	17.52	1.54	4.69	29.16	23.53
Tangible Book Value	40.49	1.65	9.1	41.74	34.82
Tangible Book Value Per Share	16.79	0.69	3.79	26.09	21.76
Buildings	-	24.24	24.74	17.96	8.24
Machinery	-	8.14	8.3	8.91	5.23
Construction In Progress	-	0.02	0.01	16.89	23.96

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2017

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error